immunoglobulin G1, anti-(human vascular endothelial growth factor) Fab fragment (human-mouse monoclonal rhuFAB V2 1-chain), disulfide with human-mouse monoclonal rhuFAB V2 light chain
Radiation Retinopathy
The New York Eye Cancer Centermonoclonal_antibodyPhase 4 / ApprovedDormant
BBB
72/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 57/ 100
- Competitive Position
- 95/ 100
Competitive context
11 Active assets in the Radiation Retinopathy cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Losartan Massachusetts General Hospital | Phase 2 | B |
RAMIPRIL Wake Forest University Health Sciences | Phase 2 | B |
Ivonescimab Zhejiang Cancer Hospital | Phase 2 | CCC |
Ozurdex Arman Mashayekhi | Phase 2 | CCC |
Chlorophyllin copper complex sodium Tata Memorial Centre | Phase 2 | CCC |
View all 14 →
Same molecule, other indications
immunoglobulin G1, anti-(human vascular endothelial growth factor) Fab fragment (human-mouse monoclonal rhuFAB V2 1-chain), disulfide with human-mouse monoclonal rhuFAB V2 light chain is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →